Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer
Haoran Feng, Kun Liu, Xiaonan Shen, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 10
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms
Jan Korbecki, Donata Simińska, Magdalena Gąssowska-Dobrowolska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10701-10701
Open Access | Times Cited: 230
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 158
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jiakang Jin, Jinti Lin, Ankai Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 122
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects
Maohua Huang, Yuning Lin, Chenran Wang, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100849-100849
Closed Access | Times Cited: 98
Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches
Jiaxuan Xia, Shaojie Ma, Xi Zhu, et al.
Science Advances (2022) Vol. 8, Iss. 6
Open Access | Times Cited: 84
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 64
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8530-8530
Open Access | Times Cited: 94
TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation
Yongchang Chen, Lu Liu, Longzheng Xia, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 51
Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
Xiang Zhang, Shangyou Zheng, Chonghui Hu, et al.
Oncogene (2022) Vol. 41, Iss. 16, pp. 2372-2389
Open Access | Times Cited: 47
Perineural invasion in colorectal cancer: mechanisms of action and clinical relevance
Hao Wang, Ruixue Huo, Kexin He, et al.
Cellular Oncology (2023) Vol. 47, Iss. 1, pp. 1-17
Open Access | Times Cited: 40
Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma
Jiazhou Ye, Xing Gao, Xi huang, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 12
Signaling pathways in colorectal cancer implications for the target therapies
Yanlin Song, Ming Chen, Yuhao Wei, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 8
RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages
Xuxue Guo, Haonan Zhang, Chengcheng He, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 7
A phase I/II study of nintedanib and capecitabine for refractory metastatic colorectal cancer
Patrick M. Boland, John M.L. Ebos, Kristopher Attwood, et al.
JNCI Cancer Spectrum (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 5
E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function
Yi Wei, Shenqi Han, Jingyuan Wen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 12
Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
Xuejin Ou, Ge Gao, Inbar A. Habaz, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 4
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
Qian Zou, Xue Lei, Aijing Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy
Zewei Tu, Chong Wang, Qing Hu, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 11
Identification of Immune Infiltration-Associated CC Motif Chemokine Ligands as Biomarkers and Targets for Colorectal Cancer Prevention and Immunotherapy
Minghao Liu, Teng Wang, Mingyang Li
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 625-625
Open Access
Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy
Jing Jiao, You Wu, Shaoxian Wu, et al.
Current Treatment Options in Oncology (2025)
Closed Access
Transcriptional regulation of ETV5 by mitogen-activated protein kinase via ETS-1 in human pancreatic cancer cells
Aya Noguchi, Masanobu Kimura, Yuriko Saiki, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance
Nannan Kang, Xue Liang, Buxi Fan, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5681-5681
Open Access | Times Cited: 15
Thymosin β4 Alleviates Autoimmune Dacryoadenitis via Suppressing Th17 Cell Response
Xiaoyu Zhao, Na Li, Ning Yang, et al.
Investigative Ophthalmology & Visual Science (2023) Vol. 64, Iss. 11, pp. 3-3
Open Access | Times Cited: 7
Translational research of new developments in targeted therapy of colorectal cancer
Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano, et al.
Pathology - Research and Practice (2023) Vol. 252, pp. 154888-154888
Closed Access | Times Cited: 7
Glioma-associated fibroblasts promote glioblastoma resistance to temozolomide through CCL2-CCR2 paracrine signaling
Mingrong Zuo, Shuxin Zhang, Siliang Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top